A nanoparticle-based formulation of sorafenib (NP-sfb) significantly inhibited hepatocellular carcinoma by suppressing angiogenesis and promoting cytotoxic T lymphocyte infiltration.

As of today, chronic inflammatory diseases are a progressive cause death worldwide, accounting for more than 50% all fatalities. These conditions major concern, ranging from heart disease to cancer, diabetes, even neurodegenerative conditions. Conventional diagnosis and treatment these problems often challenging limited due complex pathophysiology. To improve upon current diagnostic strategies,...

The application of chemotherapy in cancer treatment has been limited due to cause side effects such as toxicity against normal cells and drug resistance. In recent years, numerous studies have been focused on using natural products with chemotherapeutic drugs to enhance therapeutic efficiency and reduce cytotoxicity. On the other hand, encapsulation of drugs into nanoparticles (NPs) can improve...